生长抑素通过抑制内质网应激反应减轻肝纤维化小鼠肝损伤研究

doi:10.3969/j.issn.1672-5069.2021.02.006

实用肝脏病杂志 ›› 2021, Vol. 24 ›› Issue (2): 172-175.doi: 10.3969/j.issn.1672-5069.2021.02.006

生长抑素通过抑制内质网应激反应减轻肝纤维化小鼠肝损伤研究

都庆国, 陆建文, 王建华, 龙延滨, 薛飞

710068 西安市陕西省人民医院普外二科(都庆国,王建华,龙延滨,薛飞);
西安交通大学先进外科技术与工程研究所(陆建文,薛飞);
第一附属医院肝胆外科(陆建文)

收稿日期:2020-07-22 出版日期:2021-03-10 发布日期:2021-04-30
通讯作者: 薛飞,E-mail:xfx1129@126.com
作者简介:都庆国,男,39岁,博士研究生,副主任医师。主要从事消化外科诊断及治疗研究。E-mail:dr_duqingguo@163.com
基金资助:
陕西省自然科学基础研究计划一般项目(编号:2019JQ-973)

Somatostatin alleviates liver injury in mice with liver fibrosis by inhibiting endoplasmic reticulum stress

Du Qingguo, Lu Jianwen, Wang Jianhua, et al

Second Department of General Surgery, Provincial People's Hospital, Xi’an 710068, Shaanxi Province, China

Received:2020-07-22 Online:2021-03-10 Published:2021-04-30

摘要/Abstract

摘要： 目的观察生长抑素(SST)对肝纤维化(LF)小鼠肝组织内质网应激(ERS)反应的影响。方法将40只野生型小鼠随机分为对照组、模型组、小剂量SST干预组和大剂量SST干预组,给予小鼠腹腔内注射25% CCl₄橄榄油混合制剂制备肝纤维化模型,分别给予大、小剂量的SST进行干预。取肝组织行天狼猩红和免疫组化染色,对肝组织行Ishak评分,采用Western blot法检测肝组织Bcl-2、Bax、Casp-9、BiP和CHOP蛋白表达变化。结果模型组肝组织炎症活动度评分为(12.2±2.7),显著高于对照组[(1.8±0.8),P＜0.01],肝纤维化程度评分为(5.4±0.5),显著高于对照组[(0.1±0.3),P＜0.01];血清AST 和ALT水平分别为(194.7±35.2)U/L和(121.8±26.6)U/L],均显著高于对照组[分别为(53.8±21.7)U/L和(35.3±12.9)U/L,P＜0.01];大、小剂量SST干预组小鼠肝脏炎症活动度评分分别为(7.7±2.1)和(6.9±1.97),肝纤维化程度评分分别为(4.3±1.0)和(3.9±0.9),较模型组显著改善(P＜0.05);模型组肝组织Bax、Casp-9、BiP和CHOP蛋白相对表达量显著强于对照组([P＜0.01),而SST干预组Bax、Casp-9、BiP和CHOP蛋白相对表达量均显著弱于模型组(F=26.36,F=14.81,F=25.11和F=30.31,P＜0.05)。结论 SST能够改善CCl₄诱导的肝纤维化小鼠肝组织炎症活动和纤维化程度,其机制可能与其抑制了肝组织ERS反应有关。

关键词: 肝纤维化, 生长抑素, 内质网应激, 肝组织炎症和纤维化, 小鼠

Abstract: Objective The aim of this study was to observe the effects of somatostatin (SST) on the inflammatory response and apoptosis in mice with CCl₄-induced liver fibrosis (LF) , and to investigate whether SST can reduce liver injury and alleviate the process of LF by inhibiting the ERS.Methods Forty WT mice were randomly divided into control, model, low-dose SST-intervened and large-dose SST-intervened group, with 10 in each. Except the mice in control, the mice in other groups were injected with 25% CCl₄ and oil mixture intraperitoneally to establish the model of liver injury and the mice in SST-intervened groups were given large or low doses of SST subcutaneously, respectively. Serum ALT and AST were detected, the liver tissues were obtained for pathological examination, and the protein expression of Bcl-2, Bax, Casp-9, BiP and CHOP in liver tissues were detected by Western blot.Results The histological activity index (HAI) score in model group was (12.2±2.7), significantly higher than [(1.8±0.8), P＜0.01] in the control, and the hepatic fibrosis score was (5.4±0.5), significantly higher than [(0.1±0.3),P＜0.01] in control; serum AST and ALT in the model were (194.7±35.2)U/L and (121.8±26.6)U/L], both significantly higher than [(53.8±21.7)U/L and (35.3±12.9)U/L, respectively,P＜0.01] in the control; the HAI scores in low-dose and large-dose SST-intervened groups were (7.7±2.1) and (6.9±2.0), and the hepatic fibrosis scores were (4.3±1.0) and (3.9±0.9), significantly decreased compared to those in the model (P＜0.05); the expression of Bax, Casp-9, BiP and CHOP in hepatic tissues in the model intensified greatly compared to in the control ([P＜0.01), while the hepatic expression of Bax, Casp-9, BiP and CHOP in SST-intervened groups weaken obviously compared to in the model (F=26.36, F=14.81, F=25.11 and F=30.31,P＜0.05).Conclusion SST could alleviate liver inflammation and LF, the mechanism by which might be related to the inhibition of ERS.

Key words: Liver fibrosis, Somatostatin, Endoplasmic reticulum stress, Histological activity index, Mice

都庆国, 陆建文, 王建华, 龙延滨, 薛飞. 生长抑素通过抑制内质网应激反应减轻肝纤维化小鼠肝损伤研究[J]. 实用肝脏病杂志, 2021, 24(2): 172-175.

Du Qingguo, Lu Jianwen, Wang Jianhua, et al. Somatostatin alleviates liver injury in mice with liver fibrosis by inhibiting endoplasmic reticulum stress[J]. Journal of Practical Hepatology, 2021, 24(2): 172-175.

参考文献

[1] Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol, 2011, 6:425-456.
[2] 陈宵瑜, 杨长青. 肝纤维化发生机制研究新进展. 实用肝脏病杂志, 2016, 19(1):121-124.
[3] Schaffner F, Klion FM. Chronic hepatitis. Annu Rev Med, 1968, 19:25-38.
[4] Bravo R, Parra V, Gatica D, et al. Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration. Int Rev Cell Mol Biol, 2013, 301:215-290.
[5] Iurlaro R, Munoz-Pinedo C. Cell death induced by endoplasmic reticulum stress. FEBS J, 2016, 283(14):2640-2652.
[6] Demirtas L, Guclu A, Erdur FM, et al. Apoptosis, autophagy & endoplasmic reticulum stress in diabetes mellitus. Indian J Med Res, 2016, 144(4):515-524.
[7] 潘高峰, 傅茂英, 郜玉峰. 内质网应激与肝纤维化关系研究进展. 实用肝脏病杂志, 2018, 21(6): 987-990.
[8] Yabuki K, Maekawa T, Satoh K, et al. Extensive hemorrhagic erosive gastritis associated with acute pancreatitis successfully treated with a somatostatin analog. J Gastroenterol, 2002, 37(9):737-741.
[9] Du Z, Zhou Y, Lu X, et al. Octreotide prevents liver failure through upregulating 5'-methylthioadenosine in extended hepatectomized rats. Liver Int, 2016, 36(2):212-222.
[10] Tsuchida T, Lee YA, Fujiwara N, et al. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. J Hepatol, 2018, 69(2):385-395.
[11] Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol, 1995, 22(6): 696-699.
[12] Andruszkow J, Hartleben B, Schlué J, et al. Staging of liver fibrosis in biliary atresia : comparison of chevallier and ishak score as well as automated evaluation. Pathology, 2019, 40(1): 85-92.
[13] Zhang CY, Yuan WG, He P, et al. Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets. World J Gastroenterol, 2016, 22(48):10512-10522.
[14] El Taghdouini A, van Grunsven LA. Epigenetic regulation of hepatic stellate cell activation and liver fibrosis. Expert Rev Gastroenterol Hepatol, 2016, 10(12): 1397-1408.
[15] Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis, 2017, 37(1): 1-10.
[16] Osawa Y, Hoshi M, Yasuda I, et al. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PloS One, 2013, 8(6): e65251.
[17] Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol, 2017, 14(7):397-411.
[18] Malhi H, Kaufman RJ. Endoplasmic reticulum stress in liver disease. J Hepatol, 2011, 54(4): 795-809.
[19] Delbrel E, Soumare A, Naguez A, et al. HIF-1α triggers ERS and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosis. Sci Rep, 2018, 8(1): 17939.
[20] 甘厦, 方念, 黄神安, 等. 内镜套扎术联合生长抑素治疗肝硬化并发食管静脉曲张出血患者临床效果和安全性分析. 实用肝脏病杂志, 2019, 22(2):236-239.

生长抑素通过抑制内质网应激反应减轻肝纤维化小鼠肝损伤研究

Somatostatin alleviates liver injury in mice with liver fibrosis by inhibiting endoplasmic reticulum stress

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	彭婕, 李弼民, 雷宇鹏. 四氯化碳诱导的肝纤维化小鼠肝组织和HSC-T6细胞NOX4基因及其蛋白表达的变化[J]. 实用肝脏病杂志, 2021, 24(3): 319-322.
[2]	王丽惠, 张佳祥, 刘双平, 张惠勇, 卢秋燕, 沈培根. 原儿茶酸对刀豆蛋白A所致的免疫性肝损伤小鼠肝组织MDA、NO、SOD和GSH-PX表达的影响[J]. 实用肝脏病杂志, 2021, 24(3): 323-326.
[3]	林列坤, 卢春生, 周应生, 郑义, 杨菊红, 邹继彬, 张仁超, 梁旭竞. 慢加急性肝衰竭小鼠肝组织组蛋白去乙酰化酶mRNA水平变化[J]. 实用肝脏病杂志, 2021, 24(3): 327-330.
[4]	苏琪皓, 任丽梅, 姜凤霞, 武金宝, 江振宇. 蒙药额力根II号对肝纤维化大鼠的保护作用研究[J]. 实用肝脏病杂志, 2021, 24(2): 180-183.
[5]	代海峰, 王甜, 雷迅, 蔡佳, 黄文祥. 应用瞬时弹性成像技术联合APRI和AAR指数评估慢性乙型肝炎患者肝纤维化临床价值研究[J]. 实用肝脏病杂志, 2021, 24(2): 196-199.
[6]	吴冬秋, 崔丽华, 熊峰, 邬政宏. 血清IL-34联合超声弹性成像诊断慢性乙型肝炎患者肝纤维化的效能分析[J]. 实用肝脏病杂志, 2021, 24(1): 23-26.
[7]	刘瑞清(综述), 袁小澎(审校). 缺氧诱导因子-1α参与肝纤维化形成机制研究进展[J]. 实用肝脏病杂志, 2021, 24(1): 145-148.
[8]	宋叶雨(综述), 范建高(审校). 少肌性肥胖合并脂肪性肝病的诊断与治疗[J]. 实用肝脏病杂志, 2021, 24(1): 149-152.
[9]	黄鹤鸣, 刘彦君, 付荣, 石催催, 范建高, 张元元, 罗成, 李光明. BET抑制剂(+)-JQ1通过调节NF-KB信号通路保护小鼠急性肝衰竭实验研究^*[J]. 实用肝脏病杂志, 2020, 23(6): 781-784.
[10]	韩冬, 陆洋, 柏根基, 史昭菲. 超声声速匹配联合磁共振弥散加权成像技术评估慢性乙型肝炎患者肝纤维化程度价值分析^*[J]. 实用肝脏病杂志, 2020, 23(6): 789-792.
[11]	柳迪, 董鑫, 杨建军, 吴云英, 张龙方, 刘妍. 瞬时弹性成像联合门静脉血流动力学指标诊断慢性乙型肝炎患者肝纤维化意义探讨^*[J]. 实用肝脏病杂志, 2020, 23(6): 797-800.
[12]	唐平阳, 王洁冰, 张晓兰, 唐启群. 血清HBeAg阴性慢性乙型肝炎患者APRI、FIB-4和血清TGF-β1水平变化^*[J]. 实用肝脏病杂志, 2020, 23(6): 801-804.
[13]	崔璐瑶, 苑喜微, 刘领弟, 张莹, 赵文, 赵丹丹, 杨杨, 南月敏. 血浆GP73联合肝脏硬度检测诊断乙型和丙型肝炎患者肝纤维化临床价值分析^*[J]. 实用肝脏病杂志, 2020, 23(6): 809-812.
[14]	刘慧, 张诒凤, 郁磊. 特利加压素联合生长抑素治疗肝硬化并发上消化道出血患者疗效研究[J]. 实用肝脏病杂志, 2020, 23(6): 857-860.
[15]	张浩, 常建东, 陈小燕. 超声弹性成像结合血清学指标诊断慢性乙型肝炎患者肝纤维化价值评价[J]. 实用肝脏病杂志, 2020, 23(5): 642-645.